ConforMIS, Inc., a Bedford, MA-based medical device company developing patient-specific orthopedic implants, has expanded its Series E financing to $167.7m.
Backers included Sovereign Wealth Funds, Government Investment Funds and Private Equity Funds in the U.S., Europe, Asia and the Middle East.
The company intends to use the funds to expand commercialization of the iTotal® G2 total knee replacement system in the U.S. and abroad, advance its manufacturing capabilities and invest in new market opportunities.
Founded in 2004 and led by Philipp Lang, M.D., CEO, ConforMIS is an orthopedic company that has developed patient-specific total and partial knee replacement systems. The company uses its iFit technology to design knee implants and instrumentation for each individual patient and a just-in-time delivery model with a small sterile kit that contains the implants and disposable instruments for the procedure.
All devices have been cleared by the U.S. FDA for marketing in the US and CE Marked in Europe.